ELISA Testing of Serum Samples: How to Standardize Collection and Processing for Accurate Quantification
Does Serum Sample Quality Determine ELISA Quantitative Accuracy?
In the ELISA workflow, sample collection, processing, and storage are critical steps that determine the accuracy and reproducibility of test results. Serum is one of the most commonly used sample types, and its preparation involves natural coagulation, centrifugation, and aliquot storage. Any non-standardized operation at these steps may lead to false-positive or false-negative results.
Hemolysis, bacterial contamination, and repeated freeze-thaw cycles are the most common interference factors in serum sample testing. This article systematically describes standardized processing procedures, storage conditions, and precautions for serum samples in ELISA testing. It provides methodological references for obtaining reliable quantitative data.
What Are the General Principles of Sample Processing?
All sample collection and processing procedures should strictly follow aseptic techniques to avoid cross-contamination. Aseptic technique covers not only the selection of blood collection devices and centrifuge tubes, but also the cleanliness of the operating environment and hand disinfection of the operator. Cross-contamination may introduce exogenous proteins or enzymes, which interfere with the specificity of antigen-antibody reactions.
Samples should be processed as soon as possible after collection, and repeated freeze-thaw cycles should be minimized. Repeated freeze-thaw cycles can lead to protein aggregation, degradation, or conformational changes, which affect the accessibility of antigen epitopes. After initial processing, samples should be aliquoted into small tubes. The volume of each aliquot should match the amount needed for a single experiment. This practice avoids repeated use of the entire tube.
Sample storage conditions should be selected reasonably based on the experimental arrangement. Short-term testing can be stored at 2-8 degrees Celsius, medium-term testing at -20 degrees Celsius, and long-term storage is recommended at -80 degrees Celsius. Sample stability varies under different storage temperatures, so choices should be made based on the detection target and the expected storage duration.
How Should Serum Samples Be Collected and Prepared?
Four procedural steps govern serum preparation quality, and each one carries its own risk of introducing bias.
Blood collection uses a vacuum blood collection needle to draw fresh blood, which is then transferred into sterile tubes. Vigorous shaking during collection should be avoided to prevent mechanical hemolysis.
Natural coagulation follows, with the blood left to stand at room temperature for 1 hour after collection. Insufficient standing time may lead to incomplete serum separation, and residual fibrinogen may interfere with subsequent testing. Excessive standing time may increase the release of cellular metabolites.
Centrifugation is performed at 4 degrees Celsius and 2500 rpm for 10 minutes. Low-temperature centrifugation helps inhibit protease activity and reduce target protein degradation. After centrifugation, the upper serum layer is carefully aspirated while avoiding contact with the blood cell layer.
Aliquot storage transfers the aspirated serum into small tubes for freezing. Aliquot storage avoids repeated freeze-thaw cycles, and the freezing temperature should be selected based on the intended storage duration.
Standardized workflow for serum sample collection, coagulation, centrifugation, and storage in ELISA testing
How Should Serum Sample Storage Conditions Be Chosen?
The storage duration of serum samples is closely related to temperature. Samples can be stored at 2-8 degrees Celsius for 24-48 hours, which suits short-term testing needs. Storage at -20 degrees Celsius lasts 1 month, which suits medium-term experimental arrangements. Storage at -80 degrees Celsius lasts 6 months, which suits long-term sample repository construction.
During testing, take an appropriate amount of sample for ELISA measurement. Before sampling, the sample should be fully thawed and mixed to avoid concentration gradient-induced sampling errors. Thawed samples should be used promptly and should not be refrozen.
Which Common Interferences Should Be Avoided in Serum Testing?
Three interference sources dominate serum ELISA troubleshooting, and each has a distinct molecular basis.
Hemolysis interference arises because peroxidase-like substances released by red blood cells may cause non-specific color development in HRP-labeled ELISA. Hemolyzed samples often exhibit abnormally high absorbance values, leading to false-positive or overestimated quantitative results. Avoiding vigorous shaking and excessive centrifugation speeds during blood collection and centrifugation minimizes hemolysis.
Bacterial contamination is another concern, since bacterial cells may contain endogenous HRP that produces false-positive results. Aseptic technique should be maintained throughout sample collection, processing, and storage, and prolonged room temperature storage should be avoided.
Protein aggregation compounds both problems. Fresh serum is preferred for testing, as long-term storage may lead to increased background due to protein aggregation. Repeated freeze-thaw cycles accelerate protein aggregation and increase non-specific adsorption. Aliquot storage and the avoidance of repeated freeze-thaw cycles are key measures for reducing this interference.
How Is a Complete Quality Control Chain for Serum Samples Established?
Regardless of sample type, the principles of prompt processing, aliquot freezing, and avoiding repeated freeze-thaw cycles should be followed. For blood samples, special attention should be paid to avoiding hemolysis and bacterial contamination.
In experimental records, complete documentation of sample collection time, centrifugation conditions, storage temperature, and freeze-thaw cycles is essential. This information is crucial for troubleshooting when abnormal results occur. Consider a batch of samples that shows unusually high background signals. The same batch may also show replicate well deviations. In such cases, the sample processing records help determine whether the issue originates from the samples themselves or from the testing operations.
For new sample types or detection targets, positive and negative controls are recommended. These controls validate the suitability of the detection system in specific sample matrices.
Conclusion
The reliability of serum sample ELISA testing begins with standardized sample processing. From aseptic blood collection and natural coagulation to low-temperature centrifugation and aliquot freezing, every step affects sample integrity and the credibility of test results. Hemolysis, bacterial contamination, and protein aggregation are the most common sources of interference in serum sample testing. All three can be effectively mitigated through standardized operations and proper storage. Sample collection, processing, and ELISA testing should be treated as an integrated quality control system. That system is the foundation for obtaining accurate and reproducible data.
In cytokine testing of serum samples, selecting high-quality kits that match the detection target ensures data reliability. OneStep ELISA is a rapid detection technology that combines antigen capture and enzyme-labeled antibody binding steps. Compared with traditional ELISA, the one-step method simplifies the process. Conventional formats require multiple washing and incubation steps. The one-step format condenses them into a compact workflow of sample addition, incubation, washing, and color development. This significantly reduces testing time and minimizes operational errors. The technology suits rapid quantitative detection of target proteins in human serum or plasma samples. It enables completion of the entire process from sample addition to reading in a short time. The format is particularly suitable for scenarios requiring high throughput or rapid feedback.
These scenarios include immune function assessment, infection and inflammation research, and biomarker analysis.
Related Products
OneStep ELISA kits provide a rapid quantitative format for cytokine detection in serum and plasma matrices. The kits described below cover the major human inflammatory and immune-regulatory targets used in immune function assessment, infection and inflammation research, and biomarker analysis.
| Product Name | Catalog No. |
|---|---|
| Human IFN-γ OneStep ELISA Kit | S0C3005 |
| Human IL-6 OneStep ELISA Kit | S0C3181 |
| Human IL-1β OneStep ELISA Kit | S0C3013 |
| Mouse TNF-α OneStep ELISA Kit | S0C3023 |
Key Features
| Key Advantage | Detailed Parameter / Function |
|---|---|
| One-step simplified workflow | Combines antigen capture and enzyme-labeled antibody binding into a compact sequence of sample addition, incubation, washing, and color development, replacing the multiple washing and incubation steps of conventional ELISA. |
| Time savings and fewer errors | Shortens the interval from sample addition to signal reading, reducing hands-on time and minimizing the operational variability that accumulates across repeated manual steps. |
| Suited to serum and plasma matrices | Supports rapid quantitative detection of target proteins in human serum or plasma samples, with formats available for major human and mouse cytokine targets. |
| High-throughput compatibility | Enables batch processing for immune function assessment, infection and inflammation research, and biomarker analysis where rapid feedback is required. |
ANT BIO PTE. LTD. maintains a mature antibody development platform that spans antigen design, immunization strategy optimization, high-throughput single B cell sorting, antibody gene cloning, recombinant expression, and multi-application validation. The platform delivers systematic customization solutions for different application scenarios. To learn more about OneStep ELISA kits for serum cytokine quantification or to request a sample test, please contact us.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Starter, Absin, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
